Randhawa Amritakaur, Wylie Grant
1 Clinical Fellow in Dermatology, Department of Dermatology, Queen Elizabeth University Hospital, UK.
2 Consultant Dermatologist, Department of Dermatology, Queen Elizabeth University Hospital, UK.
Scott Med J. 2018 Aug;63(3):91-94. doi: 10.1177/0036933018763277. Epub 2018 Mar 7.
Hydroxychloroquine is considered a relatively benign drug and is regularly used by rheumatologists and dermatologists. We highlight the severe adverse drug reaction potential of this commonly prescribed medication. We report the case of a 63-year-old male, who presented with widespread skin eruption following initiation of hydroxychloroquine two weeks earlier for an inflammatory arthritis. He had typical clinical, biochemical and histological features of the now recognised formal 'diagnosis' of severe cutaneous adverse drug reaction. The culprit drug was stopped and he responded to oral and topical steroids as well as supportive measures. Severe reactions to hydroxychloroquine are uncommon; however, as in this case, drug hypersensitivity reactions often manifest in skin. In a drug normally considered to be safe, these potential cutaneous side effects should be highlighted in information given to patients prior to commencement.
羟氯喹被认为是一种相对安全的药物,风湿科医生和皮肤科医生经常使用。我们强调了这种常用处方药严重的药物不良反应可能性。我们报告了一例63岁男性病例,该患者在两周前开始服用羟氯喹治疗炎性关节炎后出现广泛皮疹。他具有目前已被认可的严重皮肤药物不良反应正式“诊断”的典型临床、生化和组织学特征。停用了致病药物,他对口服和外用类固醇以及支持性措施有反应。对羟氯喹的严重反应并不常见;然而,就像这个病例一样,药物过敏反应常表现在皮肤上。在一种通常被认为安全的药物中,这些潜在的皮肤副作用应在开始用药前告知患者的信息中予以强调。